Consolidated Statements of Operations and Comprehensive Loss - USD ($)
|
12 Months Ended |
Feb. 28, 2019 |
Feb. 28, 2018 |
Feb. 28, 2017 |
| Statement of Comprehensive Income [Abstract] |
|
|
|
| Revenue |
$ 0
|
$ 0
|
$ 0
|
| Operating Expenses |
|
|
|
| Research and development (Note 2) |
3,448,547
|
6,694,778
|
1,454,440
|
| General and administrative |
8,811,237
|
6,860,623
|
2,280,281
|
| Legal settlement (Note 15) |
4,041,627
|
0
|
0
|
| Depreciation and amortization (Notes 3 and 4) |
502,997
|
367,176
|
397,445
|
| Impairment of intangible assets (Note 4) |
298,694
|
0
|
0
|
| Interest and other finance costs (Note 7) |
467,082
|
5,125
|
0
|
| Foreign exchange loss (gain) |
(33,773)
|
109,676
|
(18,165)
|
| Total operating expenses |
17,536,411
|
14,037,378
|
4,114,001
|
| Net loss |
(17,536,411)
|
(14,037,378)
|
(4,114,001)
|
| Other comprehensive loss - |
|
|
|
| Foreign currency translation adjustment |
(121,124)
|
(17,889)
|
(157,142)
|
| Comprehensive loss |
$ (17,657,535)
|
$ (14,055,267)
|
$ (4,271,143)
|
| Loss per share - Basic and diluted |
$ (0.52)
|
$ (0.43)
|
$ (0.13)
|
| Weighted average common shares outstanding - Basic and diluted |
33,795,600
|
32,642,741
|
31,102,004
|